Geethapriya “Priya” Setty is a healthcare leader whose journey reflects curiosity, purpose, and adaptability. Beginning her career in patient care as an occupational therapist, she transitioned into broader roles within healthcare, where she now focuses on connecting people, systems, and ideas to drive meaningful impact. Known for her thoughtful leadership and collaborative approach, Priya brings a unique perspective shaped by both hands-on experience and a deep understanding of how change happens across complex environments.

Kamana Singh, Founder/CEO of APS Pharma Solutions, brings nearly two decades of experience across global pharmaceutical and biotech organizations, with deep expertise in prescription drug labeling, regulatory strategy, and cross-functional leadership. Her journey spans veterinary medicine, regulatory science, project management, consulting, and professional leadership—proving that careers don’t have to be linear to be powerful.

In this episode of the GWIS Podcast, we sit down with Dr. Qing Chang—an accomplished physician-scientist, biotech executive, and global drug development leader. Dr. Chang shares her remarkable journey from medical school in China to leading cutting-edge therapeutic programs across the U.S., Europe, and Asia. Currently the Vice President and Head of Portfolio Strategy & Program Management at Avidity Biosciences, she reflects on pivotal career moments, scientific breakthroughs, and the evolving landscape of biotech innovation.

In this episode of the GWIS Podcast, we speak with Dr. Lucy Abgaryan, a trailblazing scientist and entrepreneur with over 15 years of experience in drug development. From her groundbreaking research at The Scripps Research Institute to founding multiple biotech startups, Dr. Abgaryan shares her incredible journey and insights into innovation, leadership, and the future of science-driven entrepreneurship. Tune in to be inspired by her story!

We are thrilled to welcome Dr. Meriem Galval Cruz to our latest episode of the GWIS Podcast! With over 15 years of experience, Dr. Cruz has been at the forefront of regulatory strategy and commercialization for the development of small molecules and biologics across a wide range of therapeutic areas. Her expertise includes authoring regulatory submissions and leading the development of applications in the US and Europe, ensuring that crucial medical innovations reach those in need.

Currently at Biogen, Dr. Cruz's impressive career also includes roles as an Associate Director of Regulatory Affairs at Dunn Regulatory Associates and Senior Regulatory Scientist at Cote Orpha, LLC. At the University of Maryland, Baltimore (UMB), she played a pivotal role in bridging the gap between academic research and the pharma/biotech industry.

Dr. Cruz holds a PhD in Neuroscience from Emory University and dual BS degrees in Biology and Psychology from Florida State University. Her research, conducted during postdoctoral fellowships at UMB and the National Institutes on Drug Abuse, delved into pharmacotherapies for drug addiction and the pathophysiology of affective disorders.

Excited to introduce Dr. Sushma D.A. Hallock on our latest episode of "Graduate Women in Science"! Dive into the mind of a leader who merges the worlds of science and business with unmatched finesse. From her groundbreaking work to her commitment to Diversity, Equity, and Inclusion, discover how Dr. Hallock is paving the way for the next generation.

Charlotte Sadaka's career is a remarkable tapestry of scientific achievement and leadership in the life sciences sector. With a Ph.D. in Immunology from the esteemed Curie Institute in Paris, she embarked on a journey that took her from postdoctoral research on groundbreaking immunology to a pivotal role in biotech innovation. At Sorrento Therapeutics in San Diego, Charlotte led complex, cross-functional projects, notably in DNA-based technology and cell therapy for Alzheimer’s Disease. Her work, characterized by innovative solutions and strategic management, was instrumental in advancing pandemic response projects under DARPA funding. Charlotte's journey not only showcases her scientific prowess but also her skill in steering projects to success, earning her multiple accolades and patents, and cementing her as a luminary in the biotech landscape.